Rensselaer, New York — According to state and local economic development sources Curia plans to invest $35,000,000.00 to build out new space in Rensselaer. The company plans to occupy the new space at 33 Riverside Ave in Rensselaer, on or about July 1, 2022. According to the company website There’s no substitute for experience. Curiaformerly AMRIis an end-to-end CDMO built to help pharmaceutical and biotech companies improve patients lives. We combine a flexible suite of R&D and manufacturing capabilities with industry-leading expertise to help our partners accelerate the journey from idea to impact. The journey to medical breakthrough may be linear, but its never simple. From discovery through manufacturing, launch through commercialization, we leverage deep scientific expertise and state-of-the-art technology to ensure every stage of this intricate process advances as quickly and accurately as possible. Science is objective. Measured. Rational. That doesn’t mean its heartless. From discovery and development through manufacturing and beyond, Curia balances the science of impact with the art of possibility, working together with our partners to not only deliver therapies, but change lives for the better.

To learn more about Curia, visit http://curiaglobal.com/

Company Contact:
John Ratliff, Chief Executive Officer
518-512-2000

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved